// App-Quantinova.ai

BSH2020‐PO‐189 : Alloimmunisation in sickle cell disease in the North Central London sickle cell cohort: providing a baseline for extended red cell antigen matching and targeted donor genotyping

Researchers

Presenter

  • K. Fordwor

Principal Investigators

  • K. Madgwick

  • N. Gleadall

  • S. Trompeter

  • S. Stanworth

  • E. Aimiuwu

  • E. Prescott

  • S. Marston

  • I. Longair

  • N. Malone-Cooke

  • O. Wilkey

  • A. de Kreuk

  • E. Drasar

  • F. Shah

  • P. Eleftheriou

  • J. Porter

  • D. Roberts

  • W. Ouwehand

  • F. Regan

Medical Centers

  • Haematology, Oxford University Hospitals NHS foundation trust, Oxford, UK

  • Medicine, Buckinghamshire Healthcare NHS Foundation Trust, Amersham

  • Haematology, North Middlesex University Hospital NHS Trust, London

  • Haematology, University of Cambridge, Cambridge

  • Haematology, University College Hospitals NHS Foundation Trust

  • Pediatrics, Mt

  • Haematology, Whittington Health

  • Blood Transfusion, Health Services Laboratory

  • Paediatrics, North Middlesex University Hospital NHS Trust

  • Haematology, University College Hospitals NHS Foundation Trust

  • Department of Rheumatology, University College London, London, UK

  • School of Clinical Medicine, University of Cambridge

  • Haematology, Imperial College NHS Healthcare Trust, London

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Sickle cell anemia

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved